v3.26.3
Assets Acquisition (Tables)
 12 Months Ended
Jun. 30, 2026
Assets Acquisition [Abstract]  
Schedule of Fair Value of the Identifiable Assets The following table summarizes the fair value of the identifiable assets:

 

    Amount  
       
Total consideration in cash   $ 552,730  
         
Assets acquired and liabilities assumed:        
Cash acquired     9  
Original paid in capital paid to Hupan Pharmaceutical     276,365  
Intangible assets – license of pharmaceutical distribution     418,867  
Other payables     (37,794 )
Deferred tax liabilities     (104,717 )
Total assets acquired   $ 552,730